Tag Archive for: Bavarian Nordic

Cases of monkeypox are growing at an alarming rate and Bavarian Nordic, the company that owns Jynneos, one of the two approved vaccines, may no longer be able to keep up, according to a report by Bloomberg.

The U.S. government said on Monday it will provide states with up to 442,000 doses of Bavarian Nordic’s Jynneos vaccine to combat the outbreak of monkeypox disease.

Health officials in Europe are discussing whether to follow a move by the United States to stretch out scarce monkeypox vaccine supplies, with the World Health Organization calling for more data.

Drugmaker Bavarian Nordic said U.S. and European regulators have approved the use of Jynneos vaccine doses made at the company’s plant in Denmark as global efforts to tackle the monkeypox outbreak pick up pace.

British health agencies have secured funding to develop a standardized approach to test the performance of vaccines being used or in development against monkeypox, days after the World Health Organization (WHO) labeled the growing outbreak a global health emergency.

Bavarian Nordic, the Danish company behind the vaccine being used to try to stem a global outbreak of monkeypox, is in talks to potentially expand production capacity, its CEO said on Monday.

The approval comes just one day after the World Health Organization issued a high-level alert declaring the rapidly spreading monkeypox outbreak as a global health emergency.

The European Medicines Agency (EMA) had “adopted a positive opinion recommending that the marketing authorization for the company’s smallpox vaccine, IMVANEX, is extended to include protecting people from monkeypox disease,” Bavarian said.

Germany’s vaccine advisory committee said it urgently recommended that the country use all the monkeypox vaccine it has on hand to administer first doses, and that second shots be offered only once enough doses are available.

The U.S. government has ordered an additional 2.5 million doses of Bavarian Nordic’s vaccine for use against monkeypox and expects more later this month to fight an outbreak of the viral disease.